We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$19.2B
AUM Growth
+$2.52B
Cap. Flow
+$1.25B
Cap. Flow %
6.54%
Top 10 Hldgs %
17.34%
Holding
2,313
New
197
Increased
1,021
Reduced
855
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.67%
3 Healthcare 9.34%
4 Consumer Discretionary 9.15%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSD
976
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$2.35M 0.01%
150,556
+51,701
+52% +$814K
RNG icon
977
RingCentral
RNG
$5.28B
$2.34M 0.01%
12,490
+3,187
+34% +$708K
VVV icon
978
Valvoline
VVV
$4.51B
$2.34M 0.01%
62,717
+35,133
+127% +$1.23M
CHNG
979
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$2.34M 0.01%
109,371
-1,271
-1% -$26.7K
PPBI
980
DELISTED
Pacific Premier Bancorp
PPBI
$2.33M 0.01%
58,277
+9,332
+19% +$387K
CCL icon
981
Carnival Corporation Ltd
CCL
$39.7B
$2.33M 0.01%
115,856
+36,753
+46% +$786K
TLK icon
982
Telkom Indonesia
TLK
$14.9B
$2.33M 0.01%
80,351
+15,666
+24% +$425K
TT icon
983
Trane Technologies
TT
$106B
$2.32M 0.01%
11,488
+1,666
+17% +$313K
CZR icon
984
Caesars Entertainment
CZR
$6.14B
$2.32M 0.01%
24,792
+9,245
+59% +$937K
DSL
985
DoubleLine Income Solutions Fund
DSL
$1.24B
$2.32M 0.01%
143,776
+8,945
+7% +$153K
SBRA icon
986
Sabra Healthcare REIT
SBRA
$5.37B
$2.32M 0.01%
170,986
+102,206
+149% +$1.45M
WSM icon
987
Williams-Sonoma
WSM
$29.6B
$2.32M 0.01%
27,384
-6,316
-19% -$588K
RARE icon
988
Ultragenyx Pharmaceutical
RARE
$2.55B
$2.31M 0.01%
27,524
+2,845
+12% +$231K
MAN icon
989
ManpowerGroup
MAN
$2.63B
$2.3M 0.01%
23,662
-1,777
-7% -$178K
PTC icon
990
PTC
PTC
$16B
$2.3M 0.01%
18,981
+4,310
+29% +$519K
SLAB icon
991
Silicon Laboratories
SLAB
$7.23B
$2.29M 0.01%
11,087
+5,778
+109% +$1.06M
APLS
992
DELISTED
Apellis Pharmaceuticals
APLS
$2.28M 0.01%
48,251
+4,607
+11% +$181K
TYL icon
993
Tyler Technologies
TYL
$12.8B
$2.28M 0.01%
4,239
-2,256
-35% -$1.17M
MASI
994
DELISTED
Masimo
MASI
$2.28M 0.01%
7,781
-2,814
-27% -$801K
EHTH icon
995
eHealth
EHTH
$43.9M
$2.27M 0.01%
+89,229
New +$2.96M
FICO icon
996
Fair Isaac
FICO
$22.5B
$2.27M 0.01%
5,241
-1,418
-21% -$563K
NVO
997
Novo Nordisk
NVO
$209B
$2.27M 0.01%
40,560
-3,910
-9% -$212K
PII icon
998
Polaris
PII
$4.07B
$2.27M 0.01%
20,656
-1,175
-5% -$138K
MKTX icon
999
MarketAxess Holdings
MKTX
$5.72B
$2.26M 0.01%
5,490
-522
-9% -$206K
DVA icon
1000
DaVita
DVA
$11.7B
$2.26M 0.01%
19,825
-11,656
-37% -$1.25M

Similar funds

Guggenheim Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Guggenheim Capital held 2,313 positions worth $19.2B, up 15% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital deployed $1.25B of net new capital in Q4 2021, opening 197 new positions and adding to 1,021 existing holdings. Its largest new stake was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $28.7M trimmed.

  • Guggenheim Capital's largest Q4 2021 buy was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.
  • Guggenheim Capital added most to FIGS in Q4 2021, an estimated $173M increase.
  • Guggenheim Capital's biggest Q4 2021 reduction was Tesla, cutting an estimated $28.7M.
  • Guggenheim Capital fully exited AfterNext HealthTech Acquisition Corp Units in Q4 2021, selling an estimated $37.1M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $19.2B portfolio in Q4 2021.
  • Guggenheim Capital opened 197 new positions and closed 212 in Q4 2021.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $19.2B.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.